Estenzo, Rhea Mae .
HRN: 26-20-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2024
CEFUROXIME 1.5GM (VIAL)
11/12/2024
11/13/2024
IV
1.5gm 3 Doses
Q8
Post Cs
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes